Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,958 public trials 2,018 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

A Randomized Study in Non-Hodgkin's Lymphoma Patients Carrying Hepatitis B Surface Antigen

NCT00201318

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Mackay Memorial Hospital Taipei, Taiwan

View Trial Details

Completed

Ultrasound Biomicroscopy - Apoptosis

NCT00188370

Conditions: Carcinoma, Carcinoma, Basal Cell, Hemic and Lymphatic Diseases, +20 more
Locations: Princess Margaret Hospital Toronto, Ontario, Canada

View Trial Details

Completed

Treatment of Relapsed Low-Grade or Follicular Lymphoma With Rituximab (Also Known as Rituxan, IDEC-C2B8, IDEC-102)

NCT00168740

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

City of Hope Natioal Medical Center Duarte, California, United States

Scripps Memorial Hospital La Jolla, California, United States

UCSD Stem Cell Laboratory La Jolla, California, United States

View all 31 locations

View Trial Details

Completed

Subcutaneous Amifostine Safety Study

NCT00158041

Conditions: Cardiovascular Diseases, Digestive System Diseases, Exanthema, +30 more
Locations: Mt. Sinai Medical Center Miami Beach, Florida, United States

View Trial Details

Completed

Randomized Study for Patients With Follicular Lymphoma Needing Treatment

NCT00140569

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Groupe d'atude des lymphome de l'adulte Yvoir, Belgium

Hôpital Henri Mondor Créteil, France

Centre Léon Bérard Lyon, France

Hôpital Saint Louis Paris, France

View Trial Details

Completed

Phase II Study of Novantrone(R) (Mitoxantrone) and Etoposide in Patients With HIV Associated Large Cell and Immunoblastic Lymphomas

NCT00002003

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +24 more
Locations: UMDNJ - New Jersy Med School Newark, New Jersey, United States

New York Univ Med Ctr New York, United States

Saint Luke's - Roosevelt Hosp Ctr New York, United States

View Trial Details

Completed

Topical Use of 4,4'-Dihydroxybenzophenone-2,4-Dinitrophenylhydrazone (A-007) in the Treatment of Advanced Malignancies Including Kaposi's Sarcoma and Lymphoproliferative Disorders

NCT00002153

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +29 more
Locations: DEKK - TEC Inc New Orleans, Louisiana, United States

View Trial Details

Completed

A Study of Azidothymidine (AZT) in the Treatment of HIV Infection in Patients Receiving a Bone Marrow Transplant

NCT00002284

Conditions: AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +25 more
Locations: Johns Hopkins Hemapheresis Treatment Ctr Baltimore, Maryland, United States

View Trial Details

Completed

Study of Allogeneic Bone Marrow Transplantation Following Cyclophosphamide and Radiotherapy in Patients With Myelodysplastic Syndrome and Acute Leukemia Related to Fanconi's Anemia

NCT00005892

Conditions: Anemia, Anemia, Aplastic, Anemia, Hypoplastic, Congenital, +33 more
Locations: Fairview University Medical Center Minneapolis, Minnesota, United States

View Trial Details

Completed

Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody Plus CHOP For Untreated Mantle Cell Lymphoma

NCT00022945

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Rush-Presbyterian-St. Lukes Medical Center Chicago, Illinois, United States

Memorial Sloan-Kettering Cancer Center New York, United States

Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions